CytoDyn Inc. (CYDY)
USD 0.21
(3.13%)
USD 0.21
(3.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.98 Million | -25.11 Million | -77.72 Million | -117.57 Million | -68.8 Million | -50.46 Million |
| Net Income | -49.84 Million | -79.82 Million | -210.82 Million | -154.67 Million | -124.4 Million | -56.18 Million |
| Depreciation & Amortization | 29 Thousand | 175 Thousand | 781 Thousand | 1.79 Million | 2.03 Million | 1.24 Million |
| Deferred income taxes | - | 34.7 Million | - | 29.94 Million | 9.54 Million | -2.82 Million |
| Stock-based compensation | 2.41 Million | 4.27 Million | 6.26 Million | 10.42 Million | 6.54 Million | 3.38 Million |
| Change in working capital | 11.65 Million | -1.19 Million | -4.77 Million | -20.09 Million | -1.59 Million | 1.18 Million |
| Other non-cash items | 16.46 Million | 16.75 Million | 130.85 Million | 15.02 Million | 39.06 Million | 2.72 Million |
| Investing Cash Flow | - | - | - | -122 Thousand | -41.09 Thousand | -45.28 Thousand |
| Investments in PPE | - | - | - | -122 Thousand | -41.09 Thousand | -45.28 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -122 Thousand | -41.09 Thousand | -19.00 |
| Financing Cash Flow | 11.74 Million | 29.92 Million | 48.01 Million | 137.34 Million | 79.67 Million | 52.74 Million |
| Debt repayment | -2.01 Million | -895 Thousand | - | -950 Thousand | -2.18 Million | -14.87 Million |
| Dividends payments | -1.48 Million | - | - | -243 Thousand | - | - |
| Common Stock Repurchased | - | - | - | 138.32 Million | -8342.00 | - |
| Common Stock Issuance | 9.43 Million | 29.03 Million | 41.19 Million | 1 Million | 12.66 Million | 38.26 Million |
| Other Financing Activities | 300 Thousand | 29.03 Million | 6.81 Million | -788 Thousand | 69.2 Million | 29.35 Million |
| Accounts receivables | - | - | - | -53.01 Million | -19.03 Million | -90.82 Thousand |
| Accounts payables | 10.76 Million | -3.09 Million | -2.71 Million | 53.01 Million | 19.03 Million | 1.74 Million |
| Inventory | - | - | 2.06 Million | -74.33 Million | -19.14 Million | 90.82 Thousand |
| Other working capital | 893 Thousand | 1.9 Million | -4.12 Million | 54.24 Million | 17.55 Million | -555.02 Thousand |
| Cash at beginning of period | 9.04 Million | 4.23 Million | 33.94 Million | 14.29 Million | 3.46 Million | 1.23 Million |
| Cash at end of period | 9.81 Million | 9.04 Million | 4.23 Million | 33.94 Million | 14.29 Million | 3.46 Million |
| Capital Expenditure | - | - | - | -122 Thousand | -41.09 Thousand | -45.28 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 766 Thousand | 4.81 Million | -29.71 Million | 19.65 Million | 10.82 Million | 2.23 Million |
| Free Cash Flow | -10.98 Million | -25.11 Million | -77.72 Million | -117.69 Million | -68.84 Million | -50.51 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -49.84 Million | -16.78 Million | -11.92 Million | -9.56 Million | -11.57 Million | -79.82 Million |
| Depreciation & Amortization | 29 Thousand | 4000.00 | 7000.00 | 8000.00 | 10 Thousand | 175 Thousand |
| Deferred income taxes | - | -7.01 Million | 2.5 Million | 419 Thousand | 4.08 Million | 34.7 Million |
| Stock-based compensation | 2.41 Million | 471 Thousand | 869 Thousand | 572 Thousand | 503 Thousand | 4.27 Million |
| Change in working capital | 11.65 Million | 5.33 Million | 2.23 Million | 2.37 Million | 1.71 Million | -1.19 Million |
| Other non-cash items | 16.46 Million | 5.38 Million | 3.96 Million | 3.69 Million | 766 Thousand | 16.75 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 11.74 Million | 3.44 Million | 3.63 Million | 654 Thousand | 4.01 Million | 29.92 Million |
| Debt repayment | -2.01 Million | -2.01 Million | -654 Thousand | -213 Thousand | -1.14 Million | -895 Thousand |
| Dividends payments | -1.48 Million | -1.11 Million | - | - | - | - |
| Common Stock Repurchased | - | 1.14 Million | - | - | -1.14 Million | - |
| Common Stock Issuance | 9.43 Million | 3.44 Million | 2.68 Million | 441 Thousand | 2.57 Million | 29.03 Million |
| Other Financing Activities | 300 Thousand | 1.97 Million | 300 Thousand | 426 Thousand | 4.1 Million | 29.03 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 10.76 Million | 4.41 Million | 1.97 Million | 1.05 Million | 3.31 Million | -3.09 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 893 Thousand | 921 Thousand | 262 Thousand | 1.31 Million | -3.31 Million | 1.9 Million |
| Cash at beginning of period | 9.04 Million | 8.02 Million | 6.72 Million | 8.57 Million | 9.04 Million | 4.23 Million |
| Cash at end of period | 9.81 Million | 9.81 Million | 8.02 Million | 6.72 Million | 8.57 Million | 9.04 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 766 Thousand | 1.79 Million | 1.29 Million | -1.84 Million | -476 Thousand | 4.81 Million |
| Free Cash Flow | -10.98 Million | -1.65 Million | -2.33 Million | -2.5 Million | -4.49 Million | -25.11 Million |
BLUECLOUDS
ETIL
012690
WNBD
SOZAP
0SOM